Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
55.61
-0.43 (-0.77%)
At close: Sep 26, 2025, 4:00 PM EDT
55.79
+0.18 (0.32%)
After-hours: Sep 26, 2025, 7:59 PM EDT

Novo Nordisk Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
33.32B 33.10B 32.30B 30.97B 30.13B 28.52B 27.12B 25.20B
Diabetes Growth
10.57% 16.05% 19.11% 22.93% 24.59% 23.92% 24.31% 21.21%
Obesity
12.35B 11.34B 10.19B 8.59B 7.57B 7.01B 6.51B 5.61B
Obesity Growth
63.15% 61.82% 56.48% 53.16% 73.14% 110.41% 146.87% 159.42%
Rare Disease
3.10B 2.95B 2.91B 2.74B 2.63B 2.65B 2.68B 2.73B
Rare Disease Growth
17.73% 11.21% 8.60% 0.34% -9.75% -14.09% -16.45% -14.49%

Operating Income by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
22.00B 21.07B 19.97B 18.40B 17.35B 16.68B 15.58B 14.16B
Diabetes and Obesity Care Growth
26.80% 26.31% 28.20% 29.95% 35.29% 41.90% 47.82% 45.45%
Rare Disease
328.95M 83.80M 96.93M 103.34M 78.80M 427.60M 461.37M 362.56M
Rare Disease Growth
317.46% -80.40% -78.99% -71.50% -87.86% -50.18% -60.20% -74.47%

Revenue by Geography
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
28.96B 28.64B 27.86B 25.86B 24.68B 22.92B 21.36B 18.87B
North America Growth
17.33% 24.96% 30.41% 37.09% 44.35% 46.01% 49.97% 42.69%
International
19.81B 18.75B 17.55B 16.44B 15.65B 15.26B 14.95B 14.67B
International Growth
26.54% 22.84% 17.36% 12.08% 8.89% 11.10% 11.40% 13.54%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.